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EDITORIALCyanoacrylate Superglue to Treat Varicose Veins: Truly Ofﬁce Based and
Minimally Invasive?One of the disadvantages of endovenous therapy for abla-
tion of trunkal incompetence for patients with varicose
veins is the requirement for tumescence anaesthesia, which
may result in pain, swelling and bruising.
The use of intravenous injection of cyanoacrylate glue for
trunkal ablation is a recently developed concept. Cyanoac-
rylate glue is a liquid adhesive that has been used in
humans to treat varicosities for more than 20 years and was
ﬁrst used in endoscopic intravenous injections of peptic
varicosities.1, It has also been used in the treatment of
arteriovenous malformations. The mechanism is simple:
plasma and blood stimulates the polymerisation and leads
to closure of the target vein.2, When used as endoscopic
haemostatic or embolisation agents, it is generally very safe,
but rare cases of bleeding and pulmonary embolisation
after the use of cyanoacrylate have been reported after
endoscopic-guided injection of a peptic varix.3,4
Wang et al. demonstrated that when cyanoacrylate
mixed with lipiodol was injected into rabbit veins, the
vessels were obliterated immediately. This was followed by
a sub-acute vasculitis and a chronic granulomatous foreign
body reaction, to be replaced by ﬁbrotic tissue in 2e3
months.5, Min et al. reported that at 30 days’ post-injection,
the treated swine veins were occluded with no evidence of
recanalisation. Histological ﬁndings revealed that spindle
cells with a dense eosinophilic matrix replaced the tunica
intima and disrupted the tunica media.6, At 60 days, the
histologic changes mainly consisted of segmental wall
thickening and ﬁbrosis.7
With regard to lower limb varicose veins, the use of
a medical adhesive without thermal energy is novel.8 This
commercially available VenaSeal Sapheon closure
system is used in Europe following CE Mark approval in
September 2012, and has now been extended to South-
east Asia. The procedure is performed under local anaes-
thesia at the puncture site of the long saphenous vein in
the medial calf or thigh under ultrasound guidance, and
the catheter is placed with the help of the intravenous
guidewire with the tip at 5 cm from the saphenofemoral
junction. There is no need for peri-venous tumescence
anaesthesia during the intravenous injection of the
cyanocrylate.
The initial human pilot study was performed on eight
patients, with a mean injected volume of 1.58 ml.9 All the
veins were successfully obliterated at a 1-month follow-up.
Proebstle et al. presented the preliminary results at the
European Venous Forum in July 2011 and stated that this
new method of treating varicose veins was safe and1078-5884/$ e see front matter  2012 European Society for Vascular
Surgery. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2012.11.005effective, without the need for peri-venous injection of
anaesthesia or compression stockings.10, The results of 1-
year clinical follow-up on 38 patients who underwent
treatment of their symptomatic varicose veins with cyano-
acrylate glue injection into the long saphenous vein were
published recently.11,12 All the treated veins were closed at
24e72 h, and at 30 days, 97% of the veins were completely
closed. There were no signiﬁcant side effects or complica-
tions. The patients did not have any deep vein thrombosis
or pulmonary embolism, but Proebstle showed that the ﬁrst
8 of 38 (21%) patients had post-ablation thrombus exten-
sion through the saphenofemoral junction.13 Further
modiﬁcation of their technique with the ﬁrst cyanoacrylate
injection located 5 cm from the saphenofemoral junction
seemed to have eliminated any further post-ablation
thrombus extension.
These initial results showed that this new endovascular
technique did not require any tumescence anaesthesia or
post-procedure compression stockings. The results of the
Sapheon Closure System Feasibility Study (SCSFS)14, and the
European Sapheon Closure System Observational Prospec-
tive (eSCOPE) Trial15 are awaited to conﬁrm these results. If
conﬁrmed, with this non-thermal ablative modality, endo-
venous varicose vein surgery may become even more
minimally invasive.
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